Family and twin studies suggest that a range of neurocognitive traits index the inherited liability to ADHD; however, the utility of such measures as endophenotypes in molecular genetic studies remains largely untested. The current article examined whether the inclusion of neurocognitive measures in a genomewide linkage analysis of ADHD could aid in identifying QTL linked to the behavioral symptoms of the condition. Data were from an affected sibling pair linkage study of DSM-IV ADHD conducted at Massachusetts General Hospital. The sample included 1,212 individuals from 271 families. ADHD symptoms were assessed with the K-SADS-E. The neurocognitive battery included Wechsler Intelligence Scales subtests, the Stroop, the Wisconsin Card Sorting Test (WCST), the Rey-Osterreith Complex Figure, a working memory CPT, the CVLT and WRAT-III subscales. Evidence for linkage was assessed using a simulation-based method that combines information from univariate analyses into the equivalent of a multivariate test. After correction for multiple trait testing, a region on chromosome 3q13 showed suggestive linkage to all neurocognitive traits examined and inattention symptoms of ADHD. The second highest peak occurred on 22q12 but showed linkage to a single subscale of the WCST. In univariate analysis, this region retained criteria for suggestive linkage to this measure after correction for multiple trait testing. Our primary findings raise the possibility that one or more genes on 3q13 influence neurocognitive functions and behavioral symptoms of inattention. Overall, these data support the utility of neurocognitive traits as ADHD endophenotypes, but also highlight their limited genetic overlap with the disorder.
Family and twin studies suggest that a range of neurocognitive traits index the inherited liability to ADHD; however, the utility of such measures as endophenotypes in molecular genetic studies remains largely untested. The current article examined whether the inclusion of neurocognitive measures in a genomewide linkage analysis of ADHD could aid in identifying QTL linked to the behavioral symptoms of the condition. Data were from an affected sibling pair linkage study of DSM-IV ADHD conducted at Massachusetts General Hospital. The sample included 1,212 individuals from 271 families. ADHD symptoms were assessed with the K-SADS-E. The neurocognitive battery included Wechsler Intelligence Scales subtests, the Stroop, the Wisconsin Card Sorting Test (WCST), the Rey-Osterreith Complex Figure, a working memory CPT, the CVLT and WRAT-III subscales. Evidence for linkage was assessed using a simulation-based method that combines information from univariate analyses into the equivalent of a multivariate test. After correction for multiple trait testing, a region on chromosome 3q13 showed suggestive linkage to all neurocognitive traits examined and inattention symptoms of ADHD. The second highest peak occurred on 22q12 but showed linkage to a single subscale of the WCST. In univariate analysis, this region retained criteria for suggestive linkage to this measure after correction for multiple trait testing. Our primary findings raise the possibility that one or more genes on 3q13 influence neurocognitive functions and behavioral symptoms of inattention. Overall, these data support the utility of neurocognitive traits as ADHD endophenotypes, but also highlight their limited genetic overlap with the disorder.
INTRODUCTION
Attention deficit-hyperactivity disorder (ADHD) is a condition characterized by developmentally inappropriate levels of inattention and/or hyperactivity/impulsivity that onset in early childhood and cause impairment in multiple settings [American Psychiatric Association, 1994] . Evidence for substantial genetic influence on the disorder has been accumulating since the 1960s [Lopez, 1965] , with twin studies yielding consistent evidence of high heritability [ranging from 0.6 to 0.9; Faraone et al., 2005; Waldman and Gizer, 2006 ]. Yet, progress in revealing the genetic architecture of ADHD has been slow.
Several genes that are good biological candidates for the disorder have been implicated in meta-analyses of association studies , but polymorphisms in these genes explain only a small proportion of the variance in liability. Results from the handful of published linkage studies Ogdie et al., 2002; Bakker et al., 2003a; Arcos-Burgos et al., 2004; Asherson et al., 2008; Romanos et al., 2008] , show some degree of overlap for regions on chromosomes 5p, 9q, 16q and 17p if nominally significant findings are considered; however, no regions have achieved genomewide significance using strict criteria . This pattern of findings may, in part, reflect the low power of standard linkage studies to identify variants with modest effect sizes in complex phenotypes [Suarez et al., 1994] .
Gaining a better understanding of the etiology of ADHD is important from a public heath perspective due to the high prevalence of the disorder worldwide [approximately 8-12%; Faraone et al., 2003 ] and its association with academic and occupational failure, substance abuse, criminality and driving accidents . Given the multifactorial nature of the condition, strategies that can improve statistical power to detect risk variants of small to moderate effect are clearly desirable. One such approach that has yielded tangible results in the field of medicine [Borecki et al., 1990] is the examination of ''endophenotypes.'' Although this term has been used in a variety of ways, it predominantly refers to a phenotype that is more proximal to the biological etiology of a clinical disorder than its signs and symptoms, and is influenced by one or more of the same genes as the condition [Almasy and Blangero, 2001; Skuse, 2001; Gottesman and Gould, 2003 ]. Theoretically, the increased power gained from targeting an endophenotype compared to the disorder it underlies derives from a reduction in genetic complexity and error variance due to its greater proximity to gene products and potential to partition potentially heterogeneous pathophysiological deficits.
While the pathophysiology of ADHD has not been determined, there is strong evidence for dysfunction in prefrontalstriatal neural networks [Castellanos, 2001; Castellanos and Tannock, 2002; Faraone and Biederman, 2004] . Neurocognitive impairments in ''executive'' functions that reflect dysfunction in these pathways are wellestablished in ADHD via meta-analyses [Lijffijt et al., 2005; Martinussen et al., 2005; Willcutt et al., 2005] , are clinically relevant [Biederman et al., 2006 and are theoretically compelling as core deficits underlying the disorder [Barkley, 2006] . Recently, they have generated considerable interest as candidate endophenotypes due to evidence of impairments in unaffected siblings [Schachar et al., 2005; Doyle et al., 2005a] and unaffected co-twins [Bidwell et al., 2007] that suggest a relationship to the inherited risk for the disorder.
Despite these supporting data, designing molecular genetics studies of ADHD that include neurocognitive measures is not straightforward. First, recent analyses [Doyle, 2006; Willcutt, 2006] suggest that the familial/genetic overlap between neurocognitive performance and ADHD symptoms is partial rather than complete. As a result, studies aiming to use executive and other neurocognitive measures to find genes for ADHD must incorporate strategies to distinguish overlapping genetic influences from those that separately influence the cognitive and behavioral phenotypes. Second, prioritizing among the wide range of candidate traits is difficult because (a) inconsistencies exist regarding the specific measures of executive functions that show impairments in unaffected relatives [Doyle et al., 2005b] ; (b) weaknesses in non-executive neurocognitive traits (including sustained attention, verbal learning, processing speed and intellectual function, as well as reading and math achievement) also show associations with the condition and impairments in relatives (see Table I ); and (c) studies estimating the heritability of neurocognitive measures are small in number and predominantly based on small sample sizes [for a review see Doyle et al., 2005b] .
To date, only one published study [Rommelse et al., 2008b ] has examined candidate endophenotypes in a genomewide search for susceptibility loci for ADHD. This study found significant genomewide linkage to 2q21.1 and 13q12.11 for Motor Timing and Digit Span measures, respectively, and other regions of suggestive linkage for additional traits. Yet, because analyses incorporated ADHD symptoms as covariates, the extent to which QTL across the genome have pleitropic effects on ADHD symptoms and neurocognitive measures remains unknown. Moreover, because corrections for multiple testing of the nine phenotypes were not implemented, replications are needed to rule out the possibility of Type I error.
The current article aims to address these issues by capitalizing on a recently developed multivariate linkage approach [Ferreira et al., 2005 ] to examine the utility of candidate neurocognitive traits for understanding the genetic bases of ADHD. By first performing the multiple individual genomewide univariate analyses separately and then combining the results into the equivalent of a multivarate test, our strategy allows us to use all available data to evaluate a wide range of candidate endophenotypes without a priori assumptions about the extent of their genetic relationship to ADHD or one another. In this way, our approach represents a computationally efficient method for identifying quantitative trait loci (QTL) that regulate the expression of a single trait as well as those that contribute to two or more traits. Our overarching hypothesis is that the neurocognitive impairments in ADHD index a latent trait, or traits, that partially overlap with the heritable pathophysiology of the disorder. Thus, although the main analysis of the ADHD phenotype in our data set was negative , we predict that incorporating 
MATERIALS AND METHODS

Sample Ascertainment
Our sample consists of 1,212 individuals from 271 families enrolled in a genomewide linkage study of ADHD at the Massachusetts General Hospital. Subjects were recruited based on having at least one pair of full biological siblings meeting all diagnostic criteria for the disorder or with one member of the sibling pair meeting full and the other meeting subthreshold criteria. Full diagnoses required all DSM-IV diagnostic criteria, including age of onset prior to seven, and the presence of impairment in more than one setting. Subthreshold diagnoses were assigned when one of the following exceptions occurred: only two-thirds of the number of required symptoms, age of onset greater than seven or impairment in only a single setting.
The majority of families were ascertained through the Clinical and Research Program in Pediatric Psychopharmacology within the child psychiatry unit at the Massachusetts General Hospital (49%). Remaining families were referred from local private child psychiatry and pediatric practices (24%), newspaper and support group advertisements (18%), the outpatient psychiatry unit at Children's Hospital in Boston (5%) and an outpatient child psychiatry clinic at the University of Nebraska (4%). No ethnic or racial groups were excluded, resulting in a sample that was 95% Caucasian, 4% African American and 1% other. Potential subjects were excluded if they had been adopted, if their nuclear family was not available for study or if they did not wish to provide a blood sample for DNA extraction. Youth with major sensorimotor handicaps, active psychosis or suspected IQ less than 70 were also excluded. After being given the details of the study, parents provided written informed consent for themselves and their children, and children and adolescents provided written assent to participate. The study was approved by the Institutional Review Board of the Massachusetts General Hospital.
A two-stage procedure confirmed the diagnosis of the sib-pair. The first stage involved a telephone questionnaire with the primary caregiver that included ADHD criteria and exclusion criteria. The second stage was a clinically reviewed structured diagnostic interview (see below). Only subjects whose diagnoses were confirmed at both stages were included in the study.
Psychopathology Assessment
For youth ages 6-17, lifetime and current DSM-IV diagnoses of ADHD, in addition to a range of internalizing and externalizing Axis I disorders, were assessed using the Schedule for Affective Disorders-Child Epidemiological Version (Kiddie-SADS-E). The KSADS-E is a widely used semistructured psychiatric diagnostic interview, with established psychometric properties [Orvaschel, 1994] . For all youth, psychiatric data were collected from the mother or primary caregiver. In addition, those 12 and older were directly interviewed. Children younger than 12 were not interviewed directly because studies suggest limited reliability of interviews in young children [Edelbrock et al., 1985; Achenbach and McConaughy, 1987; Schwab-Stone et al., 1994; Breton et al., 1995] . Subjects 18 and older received the Structured Clinical Interview for DSM IV (SCID) [First et al., 1997] along with a supplement from the K-SADS-E to assess ADHD and other psychiatric disorders that onset in childhood.
Interviewers had Master's or Bachelor's degrees in psychology or a related field. They underwent a 3-month training program that included mastery of DSM-IV criteria, observation of experienced raters, and achievement of high levels of inter-rater reliability with senior raters. Kappa coefficients assessed diagnostic agreement between randomly audiotaped interviews and three board certified child and adult psychiatrists for 500 subjects. Kappas for ADHD, bipolar disorder, major depressive disorder, conduct disorder, generalized anxiety disorder and panic disorder were 0.88, 0.95, 1.0, 1.0, 0.95, and 0.95, respectively. Raters were blind to the ascertainment status of subjects because they were conducting comparable psychiatric interviews for other family studies at MGH. Final diagnoses were made after blind review of interview data by psychiatrists and clinical psychologists. The committee made a best estimate diagnosis as described by Leckman et al. [1982] . To combine discrepant parent-offspring reports, the most severe diagnosis was used unless it was felt to be unreliable.
Neurocognitive Assessment
Neurocognitive measures were administered to all subjects by psychometricians who received training and ongoing supervision by a team of licensed neuropsychologists (AED, LJS). Raters were blind to the diagnostic status of subjects.
The battery was comprised of well-studied clinical instruments selected based on evidence that they are (1) indirect indices of fronto-striatal systems; (2) associated with ADHD in meta-analyses and/or (3) impaired in unaffected co-twins or first degree relatives of affected youth. It also included an IQ screen and achievement testing. Below, we describe the tests themselves. Table I summarizes the data supporting their inclusion in the current analyses as well as the primary constructs they assess, though measures were analyzed individually because of the likelihood that they are influenced by more than one neurocognitive domain [Pennington and Ozonoff, 1996] .
The Wechsler Intelligence Scales, including the Wechsler Intelligence Scale for Children-Third Edition [Wechsler, 1991; Wechsler, 1997] for ages 6-17, and the Wechsler Adult Intelligence Scale-Third Edition [Wechsler, 1991; Wechsler, 1997] for ages 18 and older, are standardized, well-normed measures of general and specific cognitive abilities [Wechsler, 1991; Wechsler, 1997] . Measures of overall intellectual ability, verbal working memory and speed of information processing were administered. These included: (1) Vocabulary, which requires the subject to provide a verbal definition of increasingly difficult words; (2) Block Design, which requires the subject to use groups of four and then nine colored blocks to construct patterns of increasing complexity; (3) Digit Span, which requires the subject to repeat a series of orally presented digits of increasing length in forwards and reverse order; (4) Arithmetic, which requires the subject to solve orally presented arithmetic problems without the use of paper and pencil; (5) Coding/ Digit Symbol, which requires the subject to rapidly copy symbols into empty boxes using a key code; and (6) Symbol Search, which requires the subject to visually scan a set of symbols and mark the presence or absence of two target symbols.
The Wisconsin Card Sorting Test (WCST; Computerized Version) [Grant et al., 1990; Heaton et al., 1993 ] is a measure of abstract problem solving and perseveration. The task requires subjects to sort cards with differing shapes, numbers and colors to a set of stimulus cards, according to a changing set of principles. The Stroop Color Word Test [Golden, 1978] , is a measure of interference control, or the ability to carry out a primary task while suppressing a competing response. It requires subjects to read color names, name colors and then name the incongruent color in which a color name is printed. The Rey-Osterreith Complex Figure [Osterrieth, 1944] , which involves copying a complex design, provides a measure of planning and organization. Performance was assessed using the Copy Organization Score from the Developmental Scoring System [Bernstein and Waber, 1996] . The Seidman Auditory Continuous Performance Test [Seidman et al., 1998 ] is a measure of working memory that requires subjects to listen to a series of letters read aloud and tap their finger in response to certain rules. In the high working memory load condition with interference (WM-INT), subjects tap their finger after hearing an ''A'' four letters after a ''Q,'' in the presence of distractor ''Q's'' occurring between the stimulus and target. The California Verbal Learning Test-Child and Second Editions [Delis et al., 1987; Delis et al., 1994 ] assesses verbal learning. Subjects are presented with a list of words and given five trials to learn and verbally reproduce as many as they can. An interference list of words is also presented. The Wide Range Achievement TestThird Edition (WRAT-III) [Jastak and Jastak, 1993] was used to asses Arithmetic and Reading skills and involves performing mathematical calculations and pronouncing words of increasing difficulty.
Genotyping
Genotyping was completed at the Center for Inherited Disease Research (CIDR) at Johns Hopkins. Markers were derived using Illumina's Linkage IVb SNP-based marker panel based on its BeadArray TM technology on a BeadLab system. This system shows good power for mapping complex phenotypes, with a genomewide average information content of >97.1%. The panel consisted of 6,008 SNPs across all autosomes and sex chromosomes. Markers cover the genome with an average genetic distance of 0.64 cM and an average 482 kb gap. The average marker heterozygosity is 0.43 in Caucasians, 0.38 in African Americans and 0.36 in Asians. In the current data set, 1,251 DNA samples were genotyped in 279 nuclear families. Total (7,433,140) genotypes were obtained for 5,980 SNPs. Using Illumina's Gentrain software to assess the quality of genotypes, only 28 SNPs were dropped for poor performance. DNA samples from eight individuals were dropped due to poor performance. The missing data rate for 1,243 samples in the family analysis was 0.192%. The overall missing data rate after removing Mendelian inconsistencies was 0.56%. Duplicate concordance was excellent: based on 56 experimental samples genotyped in duplicate, the blinded duplicate error rate was 0.002%. Thus, overall the genotype data are of very high quality. After removal of monozygotic twins and subjects who did not complete phenotypic assessments (N ¼ 24), our total sample was comprised of 1,212 from 271 families. Table II shows a breakdown of the number of individuals genotyped per family included in the analysis of each phenotype.
To avoid biases in the estimation of identity-by-descent (IBD) probabilities, the dataset was pruned to remove correlated SNPs (r 2 > 0.2), resulting in a final set of 4885 markers. Marker physical and genetic positions were obtained from the published CIDR map http://www.cidr.jhmi.edu/ snp_marker.html.
Analytic method
Heritability estimates and genetic and environmental crosstrait correlations were calculated using SOLAR version 4.1.5 [Almasy and Blangero, 1998 ]. Heritabilities for all traits were determined by maximum likelihood univariate variance component analysis, which decomposed the expected phenotypic covariance into components due to polygenic additive genetic variance and environmental factors not shared between relatives. Given that our sample is comprised of reared together non-twin siblings, the genetic parameter, in actuality, represents the upper bound of heritability because it also includes variance due to environmental factors shared between relatives; nonetheless, it is useful for assessing the suitability of our phenotypes for inclusion in linkage analyses. The effects of age and sex covariates and a correction for proband ascertainment were included in the analyses, and the significance of models was determined by the likelihood ratio chi-square test.
To evaluate the appropriateness of our set of traits for a multivariate genetic analysis, we estimated the genetic and environmental correlations between all pairs of phenotypes using bivariate maximum likelihood variance components analyses. The genetic correlation was modeled as the correlation between the latent additive genetic factors influencing the traits and the environmental correlation as the correlation between latent environmental influences not shared between relatives. Here again, the genetic component of the correlation represents an upper-bound estimate. For 17 traits, there are 136 possible two-trait combinations and therefore 136 bivariate analyses were performed. As above, significance testing relied on likelihood ratio chi-square test as Hyperactivity symptoms  65  97  29  40  2  12  245  Inattention symptoms  65  97  29  40  2  12  245  Digit span  52  91  26  33  2  11  215  Digit symbol  51  92  26  34  2  11  216  Arithmetic  52  92  25  35  2  11  217  Symbol search  43  81  22  30  2  11  189  Color naming  47  90  25  31  2  11  206  Color word interference  45  91  25  31  2  11  205  Nonperseverative errors  42  72  22  31  2  9  178  Perseverative errors  42  73  22  31  2  9  179  Rey copy organization  48  83  24  31  2  11  199  Block design  52  87  25  34  2  11  211  Vocabulary  52  92  26  34  2  11  217  WRAT-III Reading  50  88  25  34  2  11  210  WRAT-III Arithmetic  51  93  26  33  2  11  216  Seidman WM-INT  12  41  11  16  2  8  90  CVLT  35  64  20  29  2  11  161 above, using age and sex covariates and proband ascertainment correction. To correct for multiple testing the threshold for significance of these parameters was set at P ¼ 0.05/ 136 ¼ 0.00036. Phenotypic correlations attributable to genetic and environmental factors, which are also calculated based on these models, are included in a supplementary table. Our multivariate linkage approach, which combines results from univariate analyses into a multivariate test, has been described previously [Ferreira et al., 2005 [Ferreira et al., , 2006 . Similar strategies have been used or suggested by others for multivariate linkage [Daniels et al., 1996; de Andrade et al., 1997; Buil et al., 2005] and association analyses [Hoh et al., 2001; Dudbridge and Koeleman, 2004] . Briefly, we first performed multipoint univariate linkage analyses for each of the 17 individual traits (the two ADHD symptom dimensions and the fifteen neurocognitive traits) using MERLIN-regress [Abecasis et al., 2002] , a powerful regression-based method that is robust to ascertainment. All analyses were adjusted for age and sex.
Second, for each trait, LOD scores were converted to empirical pointwise P-values (Àlog 10 P) through the analysis of 1,000 genome-scan datasets simulated under the null hypothesis of no linkage using Merlin. This step standardized the results of the individual univariate analyses, adjusting for possible biases induced by factors such normality violations, outliers or non-random missing data.
Third, at each marker, the empirical Àlog 10 P for the 17 traits were sorted and then sequentially added to represent a summary statistic (S k ) that assessed the evidence for linkage across all k traits. The significance of each of these S k statistics was then determined empirically using the simulated datasets described above. Finally, at each marker, the S k statistic with the minimum P-value was identified (denoted P min ) and its significance corrected for the number of S k statistics computed using the simulated datasets. The significance of P min represents our multivariate test for linkage, while the traits that were included in the corresponding S k statistic represent the traits with evidence for linkage to that particular marker. Suggestive and significant levels of significance were calculated using the 1,000 simulated genome-scans based on recognized guidelines [Kruglyak, and Lander 1995, #11075] .
RESULTS
Offspring were 57.6% male and had a mean age of 15.2 (SD 9.1) and a mean IQ of 107.3 (SD 14.5). ADHD diagnoses in siblings included the following proportion of DSM-IV subtypes: 56% Combined Type, 36% Predominantly Inattentive Type and 8% Predominantly Hyperactive/Impulsive Type. Rates of comorbid disorders in the offspring were as follows: oppositional defiant disorder (37.2%), conduct disorder (14.9%), major depressive disorder (13.7%), bipolar disorder (2.6%), generalized anxiety disorder (14.7%) and panic disorder (6.46%). Table III shows the genetic and environmental correlations for all pairs of phenotypes. Measures in our neurocognitive battery generally show moderate to high genetic correlations with one another, suggesting that the traits are well-suited for our multivariate linkage approach. On the other hand, the data show low to moderate genetic correlations between the ADHD symptoms and neurocognitive measures. Although these did not reach significance after a strict correction for multiple testing, it is possible that the variability of our ADHDascertained sample and/or our sample size may have limited power to determine the significance of these low-level correlations. Yet, given that many of the genetic correlations between ADHD symptoms and neurcognitive traits fall in the moderate range, which is consistent with some degree of genetic overlap, we proceeded with planned multivariate analyses of all traits. which is the best proxy for full scale IQ [Sattler, 1988, #12419] . Measures of executive functions, attention and verbal learning showed heritability estimates spanning the low to moderate range (0.17-0.47), and measures of reading and math achievement showed moderate level estimates (approximately 0.5).
Although the above estimates are consistent with the literature, the heritability of inattention and hyperactivity/impulsivity symptom dimensions were lower than expected, which may suggest that the correction used did not fully account for the selection bias introduced by the ascertainment through ADHD diagnosis. Findings from the genomewide multivariate analysis are shown in Figure 1 . Although no regions of the genome surpassed the criteria for significant linkage (empirical P < 0.00005), one region on chromosome 3q13 surpassed the threshold for suggestive linkage of P < .0015 (Table V) .
Multiple traits were individually linked to the peak marker (rs2062834) at 3q13. When considering only the best trait (the Wechsler Symbol Search test, uncorrected univariate P ¼ 0.0028), the overall evidence for linkage after correcting for the number of, and correlation between traits was P ¼ 0.0356. However, as additional traits were included in the multivariate S k sum statistic, the overall evidence for linkage to the peak marker improved, reaching a minimum of P ¼ 0.00028 when considering the top-ranked 16 traits. After correcting for the number of S k statistics computed, the multivariate evidence for linkage at rs2062834 was P ¼ 0.009 (equivalent to a w 2 ¼ 9.72 or LOD ¼ 2.11), surpassing the threshold for genomewide suggestive linkage (P < 0.0015). Based on a one LOD score drop-off from this marker, this linkage region was $16Mb long, from 108,452 to 124,567 Mb.
The second highest peak in the multivariate analysis was located on chromosome 22q12 (rs762883). Unlike the 3q13 region, the evidence for linkage at 22q12 was largely restricted to one trait (the WCST nonperseverative errors, uncorrected univariate P ¼ 0.001, corrected P ¼ 0.003), and did not improve Finally, for discussion purposes, Table VII highlights results from our multivariate and univariate analyses that overlap with the handful of genomewide linkage and other relevant studies of ADHD and neurocognition in the literature.
DISCUSSION
The current study represents the first genomewide linkage analysis to combine ADHD symptoms and candidate endophenotypes into a multivariate test to search for QTL for the disorder. Although our previous linkage scans of quantitative and dichotomous ADHD phenotypes were largely negative , this multivariate approach revealed a region on 3q13 showing suggestive linkage to symptoms of inattention as well as to a wide range of neurocognitive traits that are associated with the condition. The second highest multivariate peak occurred on 22q12 for a subtest of the Wisconsin Card Sorting Test. Overall, our findings indicate that neurocognitive measures may assist in the genetic dissection of ADHD and that one or more genes on 3q13 may influence variation in behavioral inattention and a wide range of higher order neurocognitive functions.
Endophenotypes for psychiatric disorders, though widely discussed, have rarely been used in practice, and strategies for their incorporation into molecular genetic analyses are still being developed. As Allison and colleagues point out [Allison et al., 1998 ], there are a variety of approaches to handling multiple phenotypes in general in linkage analyses, each of which has advantages and disadvantages. Conducting separate univariate analyses of each measure [Grigorenko et al., 1997] promotes interpretability and ease of replication, but results in a loss of power after correction for multiple testing to avoid Type I error. Using biometrical modeling to extract a single factor representing the common genetic variance of the neurocognitive measures and ADHD [Sham et al., 2000] is parsimonious but results in a loss of opportunity to search for QTL that influence only a subset or a single trait. Formal multivariate variance components analysis [Marlow et al., 2003] , although theoretically desirable, is computationally intensive with more than a small number of traits. This latter approach also presents challenges to the assessment of empirical significance and is not guaranteed to provide greater power than corresponding univariate analyses when the traits are moderately correlated [Amos et al., 2001; Ferreira et al., 2006] .
Our chosen strategy [Ferreira et al., 2005 [Ferreira et al., , 2006 ] combined a series of univariate analyses into the equivalent of a multivariate test and assessed their significance by simulation. The approach capitalizes on increased statistical power from the shared covariance of the behavioral and neurocognitive phenotypes when it exists, while still allowing for identification of QTL that contribute solely to individual traits or a subset of traits. Additionally, it preserves information pertaining to individual measures thereby facilitating replication in other data sets.
This approach highlighted a region on chromosome 3q13 showing suggestive linkage to ADHD inattention symptoms and all 15 neurocognitive traits examined. This region was not previously identified in the main analysis of the dichotomous ADHD phenotype and would not have reached suggestive linkage had we only performed individual univariate analyses. Therefore, provided that this result can be subsequently replicated, this finding underscores the potential of using multiple correlated endophenotypes and a multivariate approach to identify susceptibility loci for ADHD.
Although our results require replication, the area under our 3q13 peak is worthy of further investigation given that it is also a region of interest in other relevant studies. One of the nine peaks with a LOD score >1 in the Dutch [Bakker et al., 2003b] genomewide ADHD linkage scan mapped to 3q13.32 approximately 3 Mb from our peak marker (D3S2460; LOD 1.36). Additionally, Petryshen et al. [2005] identified a QTL for prepulse inhibition (PPI) of acoustic startle on a segment of mouse chromosome 16 that is syntenic with this region. PPI is thought to tap aspects of inhibitory control, attention and efficiency of information processing [Bitsios and Giakoumaki, 2005] and has been associated with prefrontal-striatal circuits in rats [Schneider and Koch, 2005] and performance on measures of executive functions in humans [Bitsios and Giakoumaki, 2005; Bitsios et al., 2006] . Linkage studies of autism [Schellenberg et al., 2006; Allen-Brady et al., 2008] , which is characterized by neurocognitive impairments in executive, attentional and verbal domains, have also highlighted this 3q13 region. Finally, our area overlaps with a region identified for reading disability [Nopola-Hemmi et al., 2001 ] which, consistent with our results, has been shown to have a genetic link to ADHD that is mediated by inattention .
Several genes in this 3q13 region are promising biological candidates for regulating the behavioral symptoms of attention and higher order neurocognition. Most notably, the Dopamine D3 receptor (DRD3) resides within 52 kb of our peak snp. Both animal models of ADHD [Russell, 2007] and the efficacy of psychostimulants [Biederman and Spencer, 2008] have implicated the dysregulation of dopamine (DA) in the pathophysiology of the disorder, and four DA-related genes (DRD4, DRD5, SLC6A3, and DBH), have previously shown association with ADHD in a meta-analysis . Although the handful of studies examining the association of DRD3 and the dichotomous diagnosis of ADHD have yielded largely negative findings for common, functional polymorphisms [Barr et al., 2000; Payton et al., 2001; Muglia et al., 2002] , none of these studies tagged the full haplotype block structure of the gene.
The distribution of DA receptors in the brain and studies of non-human primates also support its role in neurocognition [Brown et al., 1979] . Recently, Bombin et al. [2008] found that DRD3 Gly/Gly homozygotes performed more poorly on a combined measure of executive functions in healthy individuals and those with first episode psychosis; however, Rybakowski et al. [2005] found no association between DRD3 and the WCST in patients with schizophrenia. Together with our data, these findings raise the possibility that DRD3 influences the piece of the etiological puzzle of ADHD that is shared with neurocognitive traits but may have a negligible effect when the disorder is considered as a whole and/or that the specific variant in DRD3 that regulates ADHD inattention symptoms and neurocognitive traits has yet to be identified.
Genes at 3q13 that have not previously been investigated for ADHD are also targets for further study because of their potential involvement in neural development or their expression in the brain. Promising candidates at or near our peak snp include: (1) LSAMP (limbic system associated protein), which plays a role in the formation of limbic circuits and axonal growth [Pimenta et al., 1998 ]; and (2) ZNF80, a cDNA clone that codes for a zinc finger protein domain which can be part of regulatory proteins and transcription factors involved in early neural development [Di Cristofano et al., 1995] . Also within the one LOD score drop-off region is CBLB, a proto-oncogene that, Only traits with at least one region of suggestive linkage are shown.
P values shown are not corrected for multiple trait testing.
in mice, is expressed in the brain and plays a role in the synaptic mechanisms underlying long-term memory [Tan et al., 2006] . More work is needed to evaluate whether these or other genes show true association to the phenotypes linked to this region. If our results are replicated, it is intriguing to consider the mechanism by which such a wide range of phenotypes may share a genetic etiology. Although, we had anticipated partial overlap of multiple neurocognitive traits and at least one ADHD symptom dimension, our findings indicate overlap at a single locus between all 15 neurocognitive phenotypes examined and the behavioral symptoms of inattention. These findings are consistent with a growing behavioral genetics literature showing significant genetic correlations, despite low to moderate phenotypic correlations, between an extensive variety of neurocognitive traits [Butcher et al., 2006] including but not limited to correlations with IQ measures [Pedersen et al., 1994] . Based on this literature, Plomin and colleagues [Butcher et al., 2006; Kovas and Plomin, 2006] have hypothesized the existence of 'generalist genes' that influence a very diverse array of functional neurocognitive processes. Although not discounting genetic influences specific to individual traits, the proposition highlights commonalities across functions that may derive from the heritable organization of fundamental neural systems supporting cognition [Butcher et al., 2006] . The existence of one or more generalist genes at 3q13 offers a parsimonious explanation for our results, and our linkage of the behavioral manifestations of inattention to this region raises the interesting possibility that attentional processes represent a functional component of the commonalities across measures. Kovas and Plomin [2006] provide several simplified examples of how a given gene may exert pleiotropic effects on neurocognitive traits, including: (1) a gene influences a specific brain area, which in turn influences a range of neurocognitive processes; (2) a gene influences multiple brain regions, each of which affects a specific neurocognitive process; or (3) a gene influences multiple brain regions, each of which impact multiple cognitive processes. It is important to note that our data cannot distinguish between these possibilities, despite the fact that our neurocognitive measures were selected based on their potential as mediators of the relationship to ADHD (i.e., endophenotypes) and with heavy emphasis on measures tapping prefrontal-striatal network. Rather, further investigation of this region is needed to determine the underlying neurobiological mechanisms in play.
Several QTL showing suggestive linkage to individual traits also warrant further investigation, although some are likely to be false positives given multiple trait testing. Most striking is the signal on 22q12.3 for the WCST non-perseverative errors that fell just short of genomewide significance and survived correction for multiple trait testing. Previously, this region has shown linkage to bipolar disorder and schizophrenia [Badner and Gershon, 2002] , both of which show a familial relationship to impairments on the WCST [Savitz et al., 2005] , and other executive measures. Among the genes in this region, synapsin III, located at the site of our peak SNP, is a compelling candidate for further study because it plays a role in neural development and neurotransmitter release [Kao et al., 2008] .
Although not significant after correction for multiple trait testing, other univariate findings merit consideration as well. Hyperactivity symptoms showed suggestive linkage to 22q11.21. This region is well known to exhibit genomic instability, with a 3 Mb hemizygous deletion resulting in velo-cardio-facial (VCFS) syndrome, a multi-system disorder that shows a high prevalence of ADHD and behavioral dysregulation [Antshel et al., 2007] . Thus, our data lend further support to the hypothesis that one or more variants in this region influences behavioral hyperactivity.
Finally, as shown in Table VII , several neurocognitive measures showed suggestive linkage in regions overlapping with the handful of previous genomewide linkage studies of ADHD and neurocognition. Some of these and other QTL from Table VI also overlap with regions of interest from linkage studies of other psychiatric and neurodevelopmental disorders characterized by neurocognitive dysfunction, for example, autism (2q31) [Romano et al., 2005] and bipolar disorder (12q24) [Berrettini 2001 ]. Determining whether these QTL have true effects on neurocognition and possibly pleiotropic effects on other disorders will likely require larger samples since our data suggest that effects are not large and that the neurocognitive measures may themselves be complex phenotypes.
Of note is that our current findings show only limited overlap with Rommelse et al. [2008a] , which is the only genomewide linkage study to date to examine neurocognitive traits in an ADHD sample. Yet the lack of similarity to their results is understandable given that our analysis aimed to find QTL with pleiotropic effects on behavioral symptoms of ADHD and neurocognition. Thus, if our 3q13 finding is indeed real, it may not have emerged in their study because they covaried out the effects of ADHD on the neurocognitive measures before conducting their analyses. Additionally, given that their primary analyses of eight candidate endophenotypic traits and one composite measure were not corrected for multiple trait testing, Type I error cannot be ruled out. Yet, our univariate data do show a signal for color naming/processing speed on 2p in the broad vicinity of their secondary signals for motor timing and digit span. More work is needed to explore the validity of a QTL in this region for these traits. The current analyses should be considered in light of their limitations. As discussed, formal multivariate variance components analysis [Marlow et al., 2003 ] is theoretically desirable but not practical with our large number of traits and the non-normal distribution of the ADHD phenotypes. Nonetheless, we believe our approach provides a practical heuristic to combine results across individual analyses into a more powerful test, as highlighted by others [Daniels et al., 1996; de Andrade et al., 1997; Buil et al., 2005] . Additionally, the current method allowed us to use all available data for each trait, whereas data reduction via factor analysis would have required excluding traits and or individuals with missing information. Second, although our array of neurocognitive measures was chosen based on our evaluation of the empirical literature, several interesting candidate endophenotypes for ADHD were not investigated, including problems with time estimation [Smith et al., 2002; Rubia et al., 2003; Toplak et al., 2003] ; (2) variability of reaction time (RT) [Castellanos and Tannock 2002] ; and (3) preference for immediate small rewards over larger delayed ones [Sonuga-Barke et al., 1992; Kuntsi et al., 2001; Solanto et al., 2001; Sonuga-Barke, 2003 ]. Molecular genetic studies including these constructs would offer important data to the field. Third, the low correlations between ADHD symptom dimensions and the neurocognitive phenotypes in both our study and the literature suggest that ascertainment through ADHD probands is unlikely to have biased the univariate results for individual neurocognitive traits; however, replication of findings for neurocognitive measures in non-ADHD samples is also needed to confirm the 3q13 finding and determine whether our ascertainment by ADHD could have reduced power to detect signals from other QTL that jointly influence inattention and/or hyperactivity and higher order neurocognitive traits.
In conclusion, we have identified a region on chromosome 3q13 which appears to influence ADHD inattention symptoms and multiple neurocognitive measures. Overall, our results support recent twin and family studies indicating that neurocognitive measures show genetic influences that are shared with and unique from ADHD and justify their further, though cautious use in molecular genetic studies of the disorder. Yet, our findings also highlight the lack of complete genetic overlap of these behavioral and neurocognitive phenotypes and illustrate that genetic influences on associated neurocognitive traits cannot be presumed to influence ADHD. Nonetheless, revealing the genetic influences on executive and other higher order neurocognitive impairments is of considerable public health importance given the lack of available treatments and their association with poor functional outcome in the psychiatric disorders such as ADHD, schizophrenia and bipolar disorder with which they co-occur [Green, 1996; MartinezAran et al., 2004; .
